Glycine Supplement for Severe COVID-19

Clinical trial NCT04443673 · TERMINATED

Trial details

NCT number: NCT04443673
Sponsor: Instituto Nacional de Enfermedades Respiratorias
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

COVID-19 SARS-CoV Infection SARS (Severe Acute Respiratory Syndrome)SARS Pneumonia ARDS, Human Pneumonia, Viral

Start date: 2020-06-15
Primary completion: 2021-06-14
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.